Drug Interaction Report

Atenolol and Insulin Detemir: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 15, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Atenolol

Tenormin Tenormin®
+

Insulin Detemir

Levemir
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 11, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 202 documented Atenolol interactions, 158 are rated moderate — including this one.
At a glance Effects may be stronger Effects may be weaker Some uncertainty
The Bottom Line
Atenolol can hide the racing-heart warning of low blood sugar and may shift your glucose up or down, but this is manageable with more frequent monitoring and insulin dose tuning by your care team, so keep taking both as prescribed.

You're taking atenolol (a beta-blocker for blood pressure or heart) along with insulin detemir (Levemir) for blood sugar. Here's what matters: when your blood sugar drops too low, your body normally warns you with a fast, pounding heartbeat. Atenolol can quietly mute that warning sign, so a low could sneak up on you. Other warnings like sweating and shakiness usually still show up. On top of that, the combination can shift your blood sugar either up or down.

The good news is this is very manageable. Your care team can check your sugar a little more often and fine-tune your insulin dose if needed. Keep taking both as prescribed and let your pharmacist or doctor know how you're doing.

Effect: Beta-blockade may potentiate or blunt insulin's glucose-lowering effect and can mask adrenergic warning signs of hypoglycemia (notably tachycardia), while diaphoresis and dizziness are typically preserved.

  • Direction: Variable glycemic effect (hypo- or hyperglycemia); impaired counterregulation and delayed glucose recovery.
  • Mechanism: Altered glucose metabolism plus beta-adrenergic blockade. Atenolol is beta-1 selective, so masking risk is somewhat lower than with nonselective agents but still relevant.
  • Onset: Delayed. Evidence: Probable.
  • Management: Increase frequency of glucose monitoring; individualize insulin detemir dosing. If atenolol is discontinued, watch for loss of glycemic control.
Onset
delayed
Evidence
probable
Severity
Moderate

What happens

Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia

Interaction Deep Dive

The simultaneous use of antidiabetic medications with beta-blockers can produce either hypoglycemia or hyperglycemia, and may also mask the warning signs of hypoglycemia23. While tachycardia can be affected, other hypoglycemic manifestations such as dizziness and sweating are not 1. Insulin-induced hypoglycemia may be intensified by nonselective beta-blockers, which can also hinder the return of serum glucose to normal levels. Patients who have both heart failure and diabetes may experience a worsening of hyperglycemia 7. It may be necessary to check glucose more often or to modify the dose of the antidiabetic agent 23. During concurrent therapy, watch carefully for the signs and symptoms of hypoglycemia, and should the beta-blocker be discontinued, monitor for a loss of glycemic control 4.

Why it happens (mechanism)

Altered glucose metabolism and beta blockade

How to manage this interaction

This combination is commonly used and can be managed well. Typically a care team will:

  • Check blood glucose more frequently, especially when either medicine is started, stopped, or changed.
  • Adjust and individualize your insulin dose as needed based on your readings.
  • Watch for loss of blood sugar control if the atenolol is ever stopped.

What you can do: keep taking both exactly as prescribed. Learn to notice lows through sweating and shakiness, since your heartbeat cue may be muted. Report frequent highs or lows, and don't change either dose on your own. Ask your pharmacist or doctor before making any changes.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

2 reports — tap to read

a) In elderly diabetic patients receiving either insulin or sulfonylureas, the particular antihypertensive agent selected had minimal impact on hypoglycemia risk; however, once other risk factors were accounted for, the lowest risk occurred with cardioselective beta blockers and the highest with non-cardioselective beta blockers, while the remaining antihypertensive agents fell in between (N=13,559) 5.

b) In patients with hypertension and non-insulin dependent diabetes, beta blockers produced a worsening of long-term glycemic control, whereas alpha blockade and ACE inhibitors did not. Beta blockade was also associated with some detrimental effects on the lipid profile. These effects were most pronounced with propranolol. Using an alpha blocker together with the beta blocker prevented the worsening attributable to beta blockade 6.

Common questions

Can I take Atenolol and Insulin Detemir together?

Atenolol can hide the racing-heart warning of low blood sugar and may shift your glucose up or down, but this is manageable with more frequent monitoring and insulin dose tuning by your care team, so keep taking both as prescribed. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Atenolol and Insulin Detemir interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How is the Atenolol and Insulin Detemir interaction managed?

This combination is commonly used and can be managed well. Typically a care team will: Check blood glucose more frequently, especially when either medicine is started, stopped, or changed. Adjust and individualize your insulin dose as needed based on your readings. Watch for loss of blood sugar control if the atenolol is ever stopped. What you can do: keep taking both exactly as prescribed. Learn… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Atenolol or Insulin Detemir need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (7)

  1. Product Information: TENORMIN(R) oral tablets, atenolol oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2012. DailyMed
  2. Product Information: TOUJEO(R) subcutaneous injection, insulin glargine subcutaneous injection. sanofi-aventis (per manufacturer), Bridgewater, NJ, 2015. DailyMed
  3. Product Information: AMARYL(R) oral tablets, glimepiride oral tablets. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
  4. Product Information: Glynase(R) PresTab(R) oral micronized tablets, glyburide oral micronized tablets. Pharmacia & Upjohn Co (per FDA), New York, NY, 2013. DailyMed
  5. Shorr RI, Ray WA, Daugherty JR, et al: Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA 1997; 278:40-43. DOI
  6. Whitcroft IA, Thomas JM, Rawsthorne A, et al: Effects of alpha and beta adrenoceptor blocking drugs and ACE inhibitors on long term glucose and lipid control in hypertensive non-insulin dependent diabetics. Horm Metab Res Suppl 1990; 22:42-46.
  7. Product Information: COREG CR(R) extended-release oral capsules, carvedilol phosphate extended-release oral capsules. GlaxoSmithKline, Research Triangle Park, NC, 2011. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.